News
The Josep Carreras Foundation and Sant Joan de Déu Create a Childhood Leukemia Research Program Worth Over 10 Million Euros
The Josep Carreras Foundation (FJC), the Josep Carreras Leukemia Research Institute (IJC), and the Sant Joan de Déu Research Institute (IRSJD) have agreed to develop a joint research program on childhood leukemia valued at over 10 million euros.
Parc Sanitari Sant Joan de Déu Hosts the First Doctoral Thesis Defense by a Professional of the Institution at the RISE Center Auditorium
On September 30, 2025, a very special academic event took place at Parc Sanitari Sant Joan de Déu (PSSJD): the first doctoral thesis defense by a professional of the institution, held in the auditorium of the RISE center.
A study led by SJD identifies new therapeutic targets for Ewing sarcoma
The study identifies the demethylases KDM6A and KDM6B as essential collaborators of the fusion protein EWSR1::FLI1, responsible for the epigenetic reprogramming that drives tumor growth.
A study by Sant Joan de Déu identifies the mechanisms that hinder the effectiveness of treatment for diffuse intrinsic pontine glioma in children
DIPG is an aggressive brain tumor that mainly affects pediatric patients and has a poor prognosis in all cases. The research team has identified two key proteins secreted by the tumor that suppress the immune system and promote the formation of barriers that hinder treatment.
Agenda
Defensa tesi doctoral: Carmen Corral Partearroyo
"Improving initial medication adherence in primary care: pragmatic evaluation of a complex behavioural intervention"
Defensa tesi doctoral: Carmen Corral Partearroyo
"Improving initial medication adherence in primary care: pragmatic evaluation of a complex behavioural intervention"
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
